[ET Net News Agency, 28 October 2019] Shandong Xinhua Pharmaceutical Company Limited
(00719) said its net profit attributable to the shareholders of parent company was
RMB238.60 million for the nine months ended 30 September 2019, a year-on-year increase of
23.42%. The basic earnings per share were RMB0.38. No dividend will be distributed.
The operating income was RMB4.4 billion, a year-on-year increase of 11.1%. (RC)